We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva’s Orphan Leukemia Drug Lands Accelerated Approval
Teva’s Orphan Leukemia Drug Lands Accelerated Approval
November 2, 2012
Teva plans to launch its orphan chronic myeloid leukemia (CML) drug Synribo by mid-November after getting accelerated approval Oct. 26.